lung cancer
Conditions
Interventions
Chemotherapy group :
Chemo-immunotherapy group:chemo-immunotherapy
Sponsors
Affiliated Hospital of Guangdong Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Diagnosed with non-small cell lung cancer (NSCLC) through imaging and cytological examinations, with staging of II-III; 2.Pre-treatment pulmonary function FEV1 > 1.5 L; 3.Underwent neoadjuvant therapy (chemotherapy, chemo-immunotherapy, or targeted therapy) before surgery and received surgical treatment in our department (including pneumonectomy, lobectomy, and sublobar resection, along with mediastinal lymph node dissection); 4.No previous history of radiotherapy or chemotherapy.
Exclusion criteria
Exclusion criteria: 1.Combined with malignancies in other locations; 2.Liver, kidney, or heart dysfunction; 3.Presence of surgical contraindications; 4.Recurrence of non-small cell lung cancer; 5.Exploratory surgery as the surgical method; 6.Expected survival time <= 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological remission rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival,PFS;Overall survival,OS;Objective Response Rate, ORR; | — |
Countries
China
Contacts
Public ContactXie Jianlong
Affiliated Hospital of Guangdong Medical University
Outcome results
None listed